MAXI COLLAGEN^®

The design and results of the human studies related to this ingredient are described in the published journal literature.

These are study results obtained under specific test conditions and are not equivalent to finished-product effects; the timeframe observed in a study cannot be presented as a finished product’s response time.

The clinical study was conducted using 5 g of MAXI COLLAGEN® per day.

The amount used in the study is a test condition, not a recommended product dosage; the actual use level must be evaluated according to the formula, product format and target-market regulations.

MAXI COLLAGEN® can be considered for beauty-from-within product concepts.

This describes the product directions that can be evaluated; it does not mean efficacy for these concerns has been substantiated. Applicable consumer groups must be confirmed according to the complete formula and local regulations.

Collagen tripeptides, such as MAXICollal™, represent a significant breakthrough in bioavailability due to their smaller molecular size. While standard collagen peptides consist of long amino acid chains, tripeptides are composed of only three amino acids in a specific sequence (Gly-X-Y), allowing them to bypass complex digestion and be absorbed directly by the small intestine. Tripeptides have a smaller molecular size than standard collagen peptides; comparative absorption data is set out in the published study.

The absorption figure and the outcomes described are ingredient study results under specific test conditions, not finished-product effects. Permitted claims depend on the complete formula, use level, product format and target-market regulations.

Yes, for brands targeting the growing vegan sector, TCI offers VeCollal®, a biomimetic plant-based collagen alternative. Unlike traditional animal-derived collagen, VeCollal® uses fermented plant sources to mimic the exact amino acid profile of human Type 1 collagen.

Usable claims must be evaluated per formula and local regulations.

To help brands differentiate in a crowded market, TCI collaborates with medical institutions to conduct rigorous clinical testing and provide validated reports. Our research teams can analyze specific amino acid sequences and active structural regions to confirm the efficacy of a formula. TCI can arrange product-specific studies; whether a study supports a given label claim must be assessed against the regulations of the market of sale.

Clinical testing is arranged per project and results cannot be guaranteed in advance. Whether a study supports a specific label claim depends on the finished formula and the regulations of the market of sale.

Scientific rigor is maintained through a vertically integrated process that connects initial lab research directly to automated production lines. Every batch undergoes quality control measures, including stability testing, to confirm that it meets the defined ingredient specifications. This commitment to quality ensures that your brand consistently delivers high-performance functional foods that meet consumer expectations for safety and results.

Quality control confirms that batches meet defined specifications; it does not establish that a finished product reproduces the effects observed in ingredient or clinical studies. Testing scope is confirmed per project.

Sustainability is a major driver in the current market. Most premium manufacturers offer traceable sourcing, such as marine collagen from responsibly managed fisheries or bovine collagen from grass-fed sources. Additionally, plant-based alternatives are now available for brands targeting the vegan and eco-conscious demographic.

This describes general market practice, not the sourcing of any specific TCI ingredient. The source, traceability documents and sustainability certifications available for a given ingredient must be confirmed case by case.

Yes. TCI's MAXI COLLAGEN® ingredient page publishes human study results and lists the journal sources together with complete references (author, year, journal name, volume, issue and page numbers), as well as patent and award records.

When citing, it is advisable to retain the study design, the number of subjects, the observation period and the test conditions, and the wording on the ingredient page and in the original journal articles prevails; for the specific figures, see the ingredient page directly (MAXI COLLAGEN®).

The above are study results for the ingredient under specific study conditions and are not equivalent to finished-product effects. The claims that a product can use must be evaluated case by case according to the complete formula, the amount used, the product format and the regulations of the target market.

The delivery formats published on TCI's MAXI COLLAGEN® ingredient page are: Powder sachets, Capsules and Tablets.

This is not a closed list — the Q&A on the ingredient page further explains that other formats can be evaluated case by case according to the formula and process conditions; however, for formats not on the list, feasibility must not be inferred from related products, category pages or other ingredients, and must be confirmed through trial production and mass-production validation.

For the delivery format production lines TCI can provide, see the delivery format overview page (Search Delivery Formats); the specifications and published conditions of each delivery format are set out on the corresponding delivery format page.

The delivery formats, addition levels, processing conditions, sensory performance and storage stability that can actually be used must be confirmed by formulation trials, stability testing and mass-production validation results, and evaluated on a per-project basis.

The MAXI COLLAGEN® ingredient page states that a special enzymatic hydrolysis technology is used to cut collagen into low-molecular-weight collagen tripeptides, and the published molecular weight range is approximately 250–500 Da (MAXI COLLAGEN®).

This figure is a specification description published on the ingredient page; the actual testing methods, the upper and lower specification limits and the batch management items must be confirmed with formal technical documentation.

For the specifications of other ingredients, see their respective ingredient pages; the figures for this ingredient must not be used to infer them. Nucleic acid ingredients use a quality framework of “DNA fragment distribution (which can be presented by fragment length or molecular weight)”, which is not the same thing as the molecular weight specification of collagen tripeptides.